Boceprevir-Based Triple Antiviral Therapy for Chronic Hepatitis C Virus Infection in Kidney-Transplant Candidates

Background. There are few data on the combination of (pegylated-) interferon- (Peg-IFN-) α, ribavirin, and first-generation direct-acting antiviral agents (DAAs). Our aim was to describe the efficacy and safety of Peg-IFN-α, ribavirin, and boceprevir in hemodialysis patients. Patients. Six hemodialy...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Transplant
Main Authors: Mehawej, Mireille, Rostaing, Lionel, Alric, Laurent, Del Bello, Arnaud, Izopet, Jacques, Kamar, Nassim
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2015
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4519545/
https://ncbi.nlm.nih.gov/pubmed/26257919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/159795
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares